15 Burning Questions About Ozempic, Answered

When the U.S. Food and Drug Administration (FDA) approved Ozempic (semaglutide) in 2017 for use by adults with type 2 diabetes, it ushered in a new era of blood sugar and weight loss drugs. Since then, Ozempic's obesity counterpart, Wegovy, has become available. More recently, Mounjaro and Zepbound — both poised to possibly have even bigger health impacts — were also approved by the FDA.
These weight loss drugs are in a league of their own, and the news about them is everywhere. In a 2023 survey by Everyday Health with more than 3,000 participants, those who lost weight were about twice as likely to have tried these drugs than people who maintained or gained weight. Despite growing awareness of these injectables, many questions around them remain. How do they work? What are the side effects? And do you have to stay on them forever to keep the weight off?
Below are answers to common questions like these from a handful of experts: Beverly Tchang, MD, an assistant professor of clinical medicine at NewYork-Presbyterian and Weill Cornell Medicine in New York City who is board certified by the American Board of Obesity Medicine; Erin Palinski-Wade, RDN, CDCES, a nutrition and diabetes expert who practices in New Jersey; and Tiffani Bell Washington, MD, MPH, a diplomate of the American Board of Psychiatry and Neurology and of the American Board of Obesity Medicine who lives in Boston.
What Do People Need to Know About the Side Effects of Newer Drugs Linked to Weight Loss?
Next up video playing in 10 seconds
1. How Do Ozempic and Other Popular Weight Loss Drugs Work?
Besides its effect on blood sugar, GLP-1 is the primary actor behind Ozempic’s weight loss effects. “GLP-1 increases feelings of satiety and decreases appetite while also slowing digestion, which in turn mutes appetite as well,” says Palinski-Wade. She explains that the drug delays food’s exit from the stomach, keeping you feeling full longer.
“Some people feel the appetite-suppressing effects within 24 to 48 hours, but weight loss and blood sugar control will take longer,” Dr. Tchang says. “We see people lose weight and achieve blood sugar control over several months, and these benefits are sustained over a year.”
2. Who Has Had the Most Success on Ozempic So Far?
Regarding Ozempic in particular, so far it’s not clear if people in some demographics might be able to manage blood sugar better or lose more weight on the drug than others. “We don’t have that granularity of evidence yet, but we have general trends from other studies,” says Tchang. “Earlier intervention is better, because people then have fewer years of uncontrolled diabetes, and people who have higher baseline weight tend to lose more weight.”
3. Who Shouldn’t Take Ozempic?
These same restrictions hold true for Wegovy. Mounjaro and Zepbound are also not recommended during pregnancy or for people with family history of these conditions.
4. Should I Stay on Ozempic Forever?
For most people, Ozempic won’t be a short-term fix. “Semaglutide is a medication that people should take for a long time, not temporarily,” Dr. Washington says. “This is because obesity is a chronic disease, and the medication only works when you take it.” When people stop taking Ozempic, she says, they tend to regain lost weight.
So how long can you stay on Ozempic? No time limit has been established yet. (The same goes for other newer weight loss drugs.) But as long as you’re tolerating the medication well and your healthcare provider recommends it, you should be able to continue taking it.
5. I Know Ozempic Takes the Weight Off Fast. Are There Any Downsides to That?
“A loss of appetite and a decrease in calorie consumption can promote weight loss. However, it can lead to a lack of balanced nutrition and an increased risk of nutrient deficiencies,” says Palinski-Wade. These potential deficiencies could have lasting consequences. For example, if you’re not getting enough calcium and vitamin D from your diet, you could increase your risk of osteoporosis, she notes. Rapid weight loss can also lead to reduced muscle mass, which can decrease overall metabolism, strength, and balance over time.
Ozempic and the other weight loss drugs might have some drawbacks for your appearance, too. Many people report “Ozempic face,” a hollowed-out facial appearance that comes from rapidly losing fat. (Unfortunately, we can’t control which parts of our bodies lose fat the fastest or most noticeably.) Some Ozempic users even complain of “Ozempic butt.” The same principle applies: As weight comes off rapidly, it can leave your buttocks looking saggy or hollow.
6. I’ve Heard About Some Pretty Yucky Side Effects With This Drug. Should I Be Concerned?
Meanwhile, for most people, the side effects of these newer weight loss drugs are not debilitating and pass quickly. “Generally, these side effects are seen in the first few weeks of therapy as well as when dosing is increased,” Palinski-Wade says. She recommends avoiding large meals or meals high in fat to help to lessen any GI symptoms.
7. What Are the Long-Term Health Effects of Ozempic?
That said, Tchang encourages caution if you have certain risk factors. “A personal or family history of medullary thyroid cancer is a contraindication to Ozempic because this type of cancer was associated with Ozempic in animal studies,” she says. “However, it's important to discuss these concerns with your doctor, who best knows your individual circumstance.”
Like Ozempic, Mounjaro and Zepbound are so new that data on long-term effects isn’t yet available. Palinski-Wade says that thyroid tumors may eventually be a concern with these meds, too. “The FDA has warned that tirzepatide can cause thyroid tumors in rats, but we do not yet know if this will be the case in humans. More research and longer term studies are needed,” she says.
8. How Does Ozempic Affect Mental Health?
If you feel that the medication is causing or worsening psychological symptoms, talk to your doctor. “It’s important to closely monitor a person’s mood and make changes if necessary,” Washington says.
9. How Can I Get Ozempic Covered by Insurance?
Insurance coverage of Ozempic (and all drugs, for weight loss or otherwise) varies depending on your provider and plan. In many cases, if you have a valid prescription for the drug, insurance will cover at least a portion of the cost. But some insurance plans only cover Ozempic when it’s prescribed as a treatment for type 2 diabetes, not when it’s prescribed off-label as a weight loss aid. Wegovy and Zepbound, however, are FDA-approved for weight loss, and they aren't intended to be prescribed to those with diabetes.
10. What Does Ozempic Cost?
11. How Do You Get Ozempic When It’s Not Covered by Insurance?
If your insurance plan doesn’t cover Ozempic, you may have other options for reducing the drug's cost. Ozempic offers a savings card that allows users with private or commercial insurance to pay as little as $25 per pen. To access this card, your prescription must be for a one-, two-, or three-month supply, and you’ll need to answer a few qualifying questions online. If you’re interested in another weight loss drug, check out the drug's website for potential savings.
You can also ask your doctor or pharmacist for insider info on any savings or patient assistance programs in your area. Some nationwide drug discount programs like GoodRx could bring costs down.
12. Are There Cheaper Alternatives to Ozempic?
Considering the sometimes high cost of Ozempic, no one can blame you if you’re looking for a less-expensive alternative. Unfortunately, Ozempic does not have a generic alternative, Tchang says. While some websites tout knockoff versions of the drug, don’t be fooled: Faux pharmaceuticals are not a safe bet.
Some specialized pharmacies offer compounded semaglutide. These custom-made meds combine the active ingredients of Ozempic with other medications tailored to individual health needs. But Tchang says this option doesn’t have the safety backing of the branded drug. “Compounded semaglutide has not undergone the same clinical trial rigor as brand-name Ozempic, so a patient choosing this route is taking on more risk and must rely on their own research to ensure safety and efficacy.”
If you can’t afford name-brand Ozempic, Tchang says there are other possibilities for weight loss meds. “If Ozempic is inaccessible, patients should speak with a board-certified obesity medicine physician who can discuss other options, such as other GLP-1s or oral anti-obesity medications, which are typically more cost feasible,” she says.
13. How Do You Use Ozempic?
14. I’ve Heard That Zepbound and Mounjaro Are Even More Effective Than Ozempic. What Do I Need to Know About These Drugs?
Determining which drug is best for you may be a matter of assessing your health goals. One primary difference between Mounjaro and Ozempic is that Ozempic is FDA-approved to reduce the risk of heart attack and stroke in people with type 2 diabetes, while Mounjaro is not. Talk to your doctor about whether Mounjaro or Ozempic is more appropriate for you.
15. What Happens When You Stop Taking Ozempic?
Palinski-Wade says this is likely to be the reality for tirzepatide drugs as well as semaglutide. “In general, weight regain after stopping weight loss medications is always a possibility,” she says. "These medications are a tool when it comes to weight management, not a quick fix or a cure.”
Even if you stop taking your weight loss drug, you can always continue to make healthy choices that promote weight loss. “To help decrease the rebound weight gain, people can continue the lifestyle changes that they hopefully learned while taking semaglutide,” Washington says.
Everyday Health's Weight Loss Reframed Survey queried 3,144 Americans nationwide, ages 18 and older, who had tried losing weight in the previous six months. The study was fielded between July 10 and August 18, 2023, across demographic groups, genders, and health conditions. Survey recruitment took place via an online portal, in app, and via email. The margin of error for the sample size of 3,144 is +/-1.7 percent at a 95 percent confidence level.
The Takeaway
- Ozempic is a GLP-1 agonist drug that increases feelings of fullness and reduces appetite. Other weight loss drugs like Wegovy, Mounjaro, and Zepbound work in a similar way.
- Research shows that these drugs help many people lose weight, but people need to stay on the drugs to keep the weight off. These drugs may cause side effects like nausea, vomiting, and diarrhea.
- Pricing will vary depending on your insurance. Because drugs like Ozempic are relatively new, we don’t have a clear picture of their long-term health effects.
- These drugs are not recommended for people who are pregnant or have a history of diabetic retinopathy or problems with their pancreas or kidneys.

Sean Hashmi, MD
Medical Reviewer
Sean Hashmi, MD, is an experienced nephrologist and obesity medicine specialist based in Southern California. As the regional director for clinical nutrition and weight management at a prominent healthcare organization in Southern California, Dr. Hashmi oversees the development and implementation of cutting-edge nutritional programs and weight management strategies. With his innovative approach and unwavering commitment to providing evidence-based solutions, he is a highly sought-after speaker and a leader in his field.
Hashmi founded the nonprofit organization SelfPrinciple.org to provide accessible and accurate health, nutrition, and wellness information to the public. Through this platform, he shares the latest research findings, empowering individuals to make informed decisions about their well-being. Self Principle also supports children's education by providing scholarships, books, and supplies, so that students have the resources necessary to succeed academically and build a brighter future.

Sarah Garone
Author
- GLP-1 Agonists. Cleveland Clinic. July 3, 2023.
- De Block C et al. Tirzepatide for the Treatment of Adults With Type 2 Diabetes: An Endocrine Perspective. Diabetes, Obesity and Metabolism. January 2023.
- Hayes M et al. The Role of GIP in the Regulation of GLP-1 Satiety and Nausea. Diabetes. June 27, 2021.
- 59th EASD Annual Meeting of the European Association for the Study of Diabetes. Diabetologia. September 4, 2023.
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine. February 10, 2021.
- Singh G et al. Wegovy (Semaglutide): A New Weight Loss Drug for Chronic Weight Management. Journal of Investigative Medicine. January 2022.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. The New England Journal of Medicine. June 4, 2022.
- Important Safety Information. Ozempic.com.
- Prado CM et al. Muscle Matters: The Effects of Medically Induced Weight Loss on Skeletal Muscle. The Lancet: Diabetes & Endocrinology. November 2024.
- Common Side Effects. Ozempic.com.
- Sodhi M et al. Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss. JAMA. October 5, 2023.
- Jung HA et al. The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against Obesity: STEP or SURPASS? Journal of Obesity & Metabolic Syndrome. March 30, 2022.
- Drug Safety-Related Labeling Changes (SrLC): Ozempic. U.S. Food and Drug Administration. September 22, 2023.
- Meeting Highlights From the Pharmacovigilance Risk Assessment Committee (PRAC) 23–26 October 2023. European Medicines Agency. October 27, 2023.
- Fulton S et al. The Menace of Obesity to Depression and Anxiety Prevalence. Trends in Endocrinology & Metabolism. January 2022.
- Blasco BV et al. Obesity and Depression: Its Prevalence and Influence as a Prognostic Factor: A Systematic Review. Psychiatry Investigation. August 12, 2020.
- Li JR et al. Case Report: Semaglutide-Associated Depression: A Report of Two Cases. Frontiers in Psychiatry. August 29, 2023.
- Find Out the Cost for Ozempic. Novo Nordisk.
- What Is the List Price for Wegovy and Will It Impact Me? Novo Nordisk.
- How Much Should I Expect to Pay for Mounjaro? Eli Lilly.
- FDA Approves Lilly’s Zepbound (Tirzepatide) for Chronic Weight Management, a Powerful New Option for the Treatment of Obesity or Overweight with Weight-Related Medical Problems. Eli Lilly. November 8, 2023.
- Wilding J et al. Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension. Diabetes, Obesity, and Metabolism. August 2022.